Takasu; Toshiyuki

Patent Applications and Registrations

Patent applications and USPTO patent grants for Takasu; Toshiyuki.The latest application filed is for "remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient".

Company Profile

0.6.6

Takasu; Toshiyuki - Tsukubamirai N/A JP
TAKASU; Toshiyuki - Tsukuba-shi JP
Takasu; Toshiyuki - Tsukuba JP
Takasu; Toshiyuki - Chuo-ku JP
Takasu; Toshiyuki - Ibaraki JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient Grant 8,835,474 - Takasu , et al. September 16, 2	2014-09-16
Remedy For Overactive Bladder Comprising Acetic Acid Anilide Derivative As The Active Ingredient App 20110230530 - TAKASU; Toshiyuki ; et al.	2011-09-22
.alpha.-form or .beta.-form crystal of acetanilide derivative Grant 7,982,049 - Kawazoe , et al. July 19, 2	2011-07-19
Pharmaceutical Compositions For Treating Fatty Liver Disease App 20110003757 - Kurosaki; Eiji ; et al.	2011-01-06
Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient Grant 7,750,029 - Takasu , et al. July 6, 2	2010-07-06
Remedy For Overactive Bladder Comprising Acetic Acid Anilide Derivative As The Active Ingredient App 20090093529 - Takasu; Toshiyuki ; et al.	2009-04-09
Alpha-form or beta-form crystal of acetanilide derivative App 20080214633 - Kawazoe; Souichirou ; et al.	2008-09-04
.alpha.-form or .beta.-form crystal of acetanilide derivative Grant 7,342,117 - Kawazoe , et al. March 11, 2	2008-03-11
Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient App 20060115540 - Takasu; Toshiyuki ; et al.	2006-06-01
Alpha-form or beta-form crystal of acetanilide derivative App 20050004190 - Kawazoe, Souichirou ; et al.	2005-01-06
Pyrazole derivatives and compositions and methods of use as maillard reaction inhibitors Grant 5,453,514 - Niigata , et al. September 26, 1	1995-09-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.